Auditory Masking Effects on Speech Fluency in Aphasia and Apraxia of Speech
NCT ID: NCT02094014
Last Updated: 2016-05-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
46 participants
OBSERVATIONAL
2014-03-31
2015-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Modeling Treated Recovery From Aphasia
NCT03416738
Treatment for Word Retrieval Impairments in Aphasia
NCT00764400
Speech Entrainment for Aphasia Recovery
NCT04364854
Overcoming Learned Non-Use in Chronic Aphasia
NCT02012374
Phonomotor Treatment of Word Retrieval Deficits in Individuals With Aphasia
NCT01163461
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Aphasic/Apraxic Participants
The aphasic/apraxic participant group will include 30 adults who have had strokes affecting their ability to communicate verbally, broadly classified as aphasic and including individuals with and without apraxia of speech (AOS).
Participants will speak under Masked Auditory Feedback, Altered Auditory Feedback, and Normal Auditory Feedback.
Normal Auditory Feedback
Participants will produce sentences under normal speaking conditions, able to hear their own speech.
Masked Auditory Feedback
Participants will produce sentences while listening to speech-shaped noise at 85 decibels (sound pressure level) to mask ability to hear their own speech.
Altered Auditory Feedback
Participants will produce sentences while listening to their speech shifted up one octave and delayed.
Neurologically Healthy Participants
The neurologically healthy participant group will include 15 adults with no history of stroke or developmental speech or language disorder.
Participants will speak under Masked Auditory Feedback, Altered Auditory Feedback, and Normal Auditory Feedback.
Normal Auditory Feedback
Participants will produce sentences under normal speaking conditions, able to hear their own speech.
Masked Auditory Feedback
Participants will produce sentences while listening to speech-shaped noise at 85 decibels (sound pressure level) to mask ability to hear their own speech.
Altered Auditory Feedback
Participants will produce sentences while listening to their speech shifted up one octave and delayed.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Normal Auditory Feedback
Participants will produce sentences under normal speaking conditions, able to hear their own speech.
Masked Auditory Feedback
Participants will produce sentences while listening to speech-shaped noise at 85 decibels (sound pressure level) to mask ability to hear their own speech.
Altered Auditory Feedback
Participants will produce sentences while listening to their speech shifted up one octave and delayed.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Speech errors are present, but participant is able to produce approximations of words or sentences by reading or repetition; \< 90% and \> 10% on Chapel Hill Multilingual Intelligibility Test (Haley, 2011)
* Right-handed prior to stroke by report
* Normal visual attention, acuity, and color vision
* Pure-tone threshold \<= 40 decibels in at least one ear
* Matched in age and sex to a participant with aphasia
* score of 90% or higher on the single-word intelligibility test
* Right-handed prior to stroke by report
* Normal visual attention, acuity, and color vision
* Pure-tone threshold \<= 40 decibels in at least one ear
Exclusion Criteria
* Presence of degenerative neurological illness (e.g. Parkinson's disease, amyotrophic lateral sclerosis, primary progressive aphasia).
* History of stroke
* History of developmental speech or language disorder
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Deafness and Other Communication Disorders (NIDCD)
NIH
University of North Carolina, Chapel Hill
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Adam Jacks, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
University of North Carolina, Chapel Hill
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of North Carolina School of Medicine
Chapel Hill, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
10-0503
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.